Oragenics (OGEN) Competitors $1.39 -0.04 (-2.80%) Closing price 04:00 PM EasternExtended Trading$1.39 +0.00 (+0.29%) As of 08:00 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesSEC FilingsShort InterestTrendsBuy This Stock OGEN vs. SNGX, DRMA, RDHL, ALBT, SPRC, VRAX, THAR, TTNP, PBM, and EVAXShould you be buying Oragenics stock or one of its competitors? The main competitors of Oragenics include Soligenix (SNGX), Dermata Therapeutics (DRMA), Redhill Biopharma (RDHL), Avalon GloboCare (ALBT), SciSparc (SPRC), Virax Biolabs Group (VRAX), Tharimmune (THAR), Titan Pharmaceuticals (TTNP), Psyence Biomedical (PBM), and Evaxion A/S (EVAX). These companies are all part of the "pharmaceutical products" industry. Oragenics vs. Its Competitors Soligenix Dermata Therapeutics Redhill Biopharma Avalon GloboCare SciSparc Virax Biolabs Group Tharimmune Titan Pharmaceuticals Psyence Biomedical Evaxion A/S Soligenix (NASDAQ:SNGX) and Oragenics (NYSE:OGEN) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, valuation, profitability, institutional ownership, media sentiment, earnings, risk and analyst recommendations. Is SNGX or OGEN more profitable? Soligenix's return on equity of -223.89% beat Oragenics' return on equity.Company Net Margins Return on Equity Return on Assets SoligenixN/A -223.89% -103.50% Oragenics N/A -2,087.95%-486.56% Do institutionals & insiders believe in SNGX or OGEN? 3.6% of Soligenix shares are owned by institutional investors. Comparatively, 18.7% of Oragenics shares are owned by institutional investors. 3.1% of Soligenix shares are owned by insiders. Comparatively, 4.9% of Oragenics shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term. Which has preferable valuation and earnings, SNGX or OGEN? Soligenix has higher revenue and earnings than Oragenics. Soligenix is trading at a lower price-to-earnings ratio than Oragenics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSoligenix$120K35.86-$8.27M-$4.29-0.31OragenicsN/AN/A-$20.66M-$33.63-0.04 Does the media prefer SNGX or OGEN? In the previous week, Soligenix had 2 more articles in the media than Oragenics. MarketBeat recorded 2 mentions for Soligenix and 0 mentions for Oragenics. Soligenix's average media sentiment score of 0.60 beat Oragenics' score of 0.00 indicating that Soligenix is being referred to more favorably in the media. Company Overall Sentiment Soligenix Positive Oragenics Neutral Do analysts prefer SNGX or OGEN? Soligenix presently has a consensus target price of $6.00, indicating a potential upside of 354.55%. Given Soligenix's stronger consensus rating and higher possible upside, analysts plainly believe Soligenix is more favorable than Oragenics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Soligenix 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00Oragenics 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Which has more volatility and risk, SNGX or OGEN? Soligenix has a beta of 1.87, meaning that its stock price is 87% more volatile than the S&P 500. Comparatively, Oragenics has a beta of 0.95, meaning that its stock price is 5% less volatile than the S&P 500. SummarySoligenix beats Oragenics on 11 of the 14 factors compared between the two stocks. Get Oragenics News Delivered to You Automatically Sign up to receive the latest news and ratings for OGEN and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding OGEN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart OGEN vs. The Competition Export to ExcelMetricOragenicsPharmaceutical IndustryMedical SectorNYSE ExchangeMarket Cap$1.18M$776.90M$5.70B$21.12BDividend YieldN/A4.84%4.69%3.60%P/E Ratio-0.201.4028.0728.44Price / SalesN/A25.35448.5760.38Price / CashN/A19.5636.2222.92Price / Book2.286.798.664.69Net Income-$20.66M-$4.32M$3.25B$995.51M7 Day Performance2.96%1.33%4.20%1.64%1 Month Performance-59.83%3.74%10.82%5.92%1 Year Performance-95.41%8.18%34.70%11.50% Oragenics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)OGENOragenics0.1024 of 5 stars$1.39-2.8%N/A-95.5%$1.18MN/A-0.205SNGXSoligenix2.5923 of 5 stars$1.43+1.4%$6.00+319.6%-70.8%$4.66M$120K-0.3320DRMADermata Therapeutics2.7921 of 5 stars$0.73+4.3%$3.00+312.7%-73.8%$4.64MN/A-0.048RDHLRedhill BiopharmaN/A$1.99-8.5%N/A-99.2%$4.64M$8.04M0.00210Gap UpALBTAvalon GloboCare3.1629 of 5 stars$2.39-1.4%N/A-63.0%$4.55M$1.33M-0.125Positive NewsGap UpSPRCSciSparc0.8628 of 5 stars$8.27+1.0%N/A-34.3%$4.38M$1.31M0.004VRAXVirax Biolabs Group2.4895 of 5 stars$1.00-2.0%$3.00+201.5%-6.4%$4.37M$10K0.005THARTharimmune3.0679 of 5 stars$1.64+1.2%$17.00+936.6%-51.1%$4.36MN/A-0.212TTNPTitan Pharmaceuticals0.304 of 5 stars$4.69-1.9%N/A-14.2%$4.27M$180K-1.0210Positive NewsGap UpPBMPsyence Biomedical0.755 of 5 stars$7.27+0.3%N/A-95.7%$4.08MN/A0.00N/AEVAXEvaxion A/S2.8499 of 5 stars$2.73+4.4%$10.00+267.0%-82.0%$3.82M$3.29M-2.3560Gap Down Related Companies and Tools Related Companies Soligenix Competitors Dermata Therapeutics Competitors Redhill Biopharma Competitors Avalon GloboCare Competitors SciSparc Competitors Virax Biolabs Group Competitors Tharimmune Competitors Titan Pharmaceuticals Competitors Psyence Biomedical Competitors Evaxion A/S Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:OGEN) was last updated on 7/25/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredTrump’s betrayal exposed Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredTreasury Secretary Bessent Is Betting Big on GoldWhen the U.S. Treasury Secretary’s largest personal investment is gold — that’s a signal. Now a veteran gol...Golden Portfolio | SponsoredTurn $1K into $50K with This DeFi GemI've never been more confident about a DeFi opportunity. This isn't about complex trading or risky bets. Th...Crypto 101 Media | SponsoredHow to Collect Up To $5,917/mo From Trump’s Made In USA BoomHow to Collect Up To $5,917/mo From Trump's Made In USA Boom Thanks to President Trump's America-First poli...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Oragenics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Oragenics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
